Overview

Dose Reduction of Lopinavir in Children

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in ARV PI naive HIV-1 infected Thai children. To study clinical and immunological efficacy after 48 weeks of lopinavir/ritonavir in PI naïve HIV-1 infected Thai children

Phase:

Phase 2

Details

Lead Sponsor:

The HIV Netherlands Australia Thailand Research Collaboration

Collaborator:

Ministry of Education, Thailand

Treatments:

Lamivudine
Lopinavir
Ritonavir
Zidovudine